Construction, propagation, and titer estimation of recombinant adenoviruses carrying proapoptotic genes

Human Gene Therapy

Volumn 9, Issue 18, 1998, Pages 2683-2689

  Shinoura, Nobusada ^a,b   Ohashi, Makoto ^a   Yoshida, Yoko ^a   Asai, Akio ^b   Kirino, Takaaki ^b,c   Saito, Izumu ^b   Hamada, Hirofumi ^a  

^a CANCER INSTITUTE   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE INHIBITOR; FAS ANTIGEN; FAS LIGAND;

ADENOVIRUS; APOPTOSIS; ARTICLE; NONHUMAN; VIRUS RECOMBINANT; VIRUS REPLICATION; VIRUS TITRATION;

ADENOVIRIDAE; DNA VIRUSES;

EID: 0032506718     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1998.9.18-2683     Document Type: Article

References (12)

1. ARAI, H., GORDON, D., NABEL, E.G., and NABEL, G.J. (1997). Gene transfer of Fas ligand induces tumor regression in vivo. Proc. Natl. Acad. Sci. U.S.A. 94, 13862-13867,
2. KANEGAE, Y., LEE, G., SATO, Y., TANAKA, M., NAKAI, M., SAKAKI, T., SUGANO, S., and SAITO, I. (1995). Efficient gene activation in mammalian cells by using recombinant adenovirus expressing site-specific Cre recombinase. Nucleic Acids Res. 23, 3816-3821.
3. KANG, S.M., SCHNEIDER, D.B., LIN, Z., HANAHAN, D., DICHEK, D.A., STOCK, P.G., and BAEKKESKOV, S. (1997). Fas ligand expression in islets of Langerhans does not confer immune privilege and instead targets them for rapid destruction. Nature Med. 3, 738-743.
4. KOBAYASHI, K., KAMAKURA, T., TANAKA, T., YAMAGUCHI, I., and ENDO, T. (1991). Nucleotide sequence of the bsr gene and N-terminal amino acid sequence of blasticidin S deaminase from blasticidin S resistant Escherichia coli TK121. Agric. Biol. Chem. 55, 3155-3157.
5. LAU, H.T., YU, M., FONTANA, A., and STOECKART, C.J. (1996). Prevention of islet allograft rejection with engineered myoblasts expressing FasL in mice. Science 273, 109-112.
6. MITA, E., HAYASHI, N., IIO, S., TAKEHARA, T., HIJIOKA, T., KASAHARA, A., FUSAMOTO, H., and KAMADA, T. (1994). Role of Fas ligand in apoptosis induced by hepatitis C virus infection. Biochem. Biophys. Res. Commun. 204, 468-474.
7. MIYAKE, S., MAKIMURA, M., KANEGAE, Y., HARADA, S., SATO, Y., TAKAMORI, K., TOKUDA, C., and SAITO, I. (1996). Efficient generation of recombinant adenoviruses using adenovirus DNA-terminal protein complex and a cosmid bearing the full-length virus genome. Proc. Natl. Acad. Sci. U.S.A. 93, 1320-1324.
8. MURUVE, D.A., NICOLSON, A.G., MANFRO, R.C., STROM, T.B., SUKHATME, V.P., and LIBERMANN, T.A. (1997). Adenovirus-mediated expression of Fas ligand induces hepatic apoptosis after systemic administration and apoptosis of ex vivo-infected pancreatic islet allografts and isografts. Hum. Gene Ther. 8, 955-963.
9. PICKUP, D.J., INK, B.S., HU, W., RAY, C.A., and JOKLIK, W.K. (1986). Hemorrhage in lesions caused by cowpox virus is induced by a viral protein that is related to plasma protein inhibitors of serine proteases. Proc. Natl. Acad. Sci. U.S.A. 83, 7698-7702.
10. SHINOURA, N., YOSHIDA, Y., SADATA, A., HANADA, K., YAMAMAOTO, S., KIRINO, T., ASAI, A., and HAMADA, H. (1998). Apoptosis by retrovirus- and adenovirus-mediated gene transfer of Fas ligand to glioma cells: Implications for gene therapy. Hum. Gene Ther. 9, 1983-1993.
11. WAKIMOTO, H., YOSHIDA, Y., AOYAGI, M., HIRAKAWA, K., and HAMADA, H. (1997). Efficient retrovirus-mediated cytokinegene transduction of primary-cultured human glioma cells for tumor vaccination therapy. Jpn. J. Cancer Res. 88, 296-305.
12. YOSHIDA, Y., EMI, N., and HAMADA, H. (1997). VSV-G-pseudotyped retroviral packaging through adenovirus-mediated inducible gene expression. Biochem. Biophys. Res. Commun. 232, 379-382.